Behavioral Effects of SQSTM1/p62 Overexpression in Mice: Support for a Mitochondrial Role in Depression and Anxiety Michael Lamar Seibenhener, Ph.D. Department.

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Growth Factor (GF) Cascades and exercise and the regulation of cognition, mood and motor control: Are GFs a common mechanism? Carl W. Cotman Director,
- D A N I S H A G I N G R E S E A R C H C E N T E R - Why do we age so differently? Tinna Stevnsner for Christina Poulsen Hvitby (on maternity.
Etiopathogenesis of Alzheimer's disease
MITOCHONDRIAL DISEASES
Healthy Mitochondria. Reactive Oxygen Species (ROS) Production Regulated by several factors Regulated by several factors ROS are formed by Oxidative Phosphorylation.
Question: What do we know about the elusive nature of the pathogenesis of Alzheimer's disease? How can personalized medicine, or the application of genomics.
Astrocytic contribution to deficient Ca 2+ signalling and oxidative stress mediated by TRPV4 channels in Aβ 40 -induced hippocampal cell death Ji-Zhong.
Abby Suelflow 9 April  Distributed in many regions of adult brain  Multiple BDNF transcripts that encode exact same protein  BDNF promotors involved.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Apoptosis, controlled cell death, is a natural process of development. Recently it has been found that mitochondria play an important role in apoptosis.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
FTD Family Members Study & Post Mortem Study Alyson Negreira MGH Frontotemporal Disorders Unit.
AMPAKINE Compounds for the Treatment of Rett Syndrome
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
Sleep Deprivation Effects on Memory and Anxiety in Mice Eyitemi Opuogen Department of Biology, York College of Pennsylvania Sleep is imperative for a person’s.
Neural Progenitor Cells as Replacement Therapy for Diseased and Aging Brains. R.G. Jarman, E. Alveraz, C.R. Freed; Division of Clinical Pharmacology, Dept.
Nature may have the answers for Alzheimer’s disease Sungkwon Chung Dept. of Physiology Sungkyunkwan University School of Medicine.
Diseases that Result from Abnormal Mitochondrial Function Lu Qiping April 15, 2011.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Molecular mechanisms of memory. How does the brain achieve Hebbian plasticity? How is the co-activity of presynaptic and postsynaptic cells registered.
The aging phenotype: cellular aspects A&S Jim Lund.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Alzheimer’s Disease. Alzheimer's is a the most common form of dementia. Nearly 50-80% of all dementia patients have Alzheimer's. It is a progressive fatal.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
An Important Role of Neural Activity-Dependent CaMKIV Signaling in the Consolidation of Long- Term Memory Hyejin Kang, Linus D. Sun, Coleen M. Atkins,
Introduction The Sigma-1 receptor was discovered in 1976 by pharmacological studies with drug addiction model systems. More recently, it has been found.
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
The role of CD44 in response to stress Life Science Research Project Laboratory: The Neuroscience Lab, Felsenstein Medical Research Center, Tel-Aviv University,
Dr. Sigal fleisher-Berkovich Neuroinflammation is regulated by angiotensin related drugs: possible implications for neurodegenerative diseases.
Mitochondria and Autism
ALZHEIMER’S WHAT IS IT – WHAT TO DO ABOUT IT. VIDEO
Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.
Under the supervision of miklós jászberényi
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Fukuda et al Working Memory Both the medial prefrontal cortex (mPFC) and hippocampus are implicated in working memory.
AGING DEATH AND BEREAVEMENT. AGING AGING By % of population of us will be above 65 yrs. By % of population of us will be above 65 yrs. The.
Genetic enhancement of learning and memory in mice. Tang YP et al.
Pathogenesis and pathology of parkinsonism
Introduction Zebrafish (Danio rerio) have become an increasingly popular animal model for the study of anxiety. A variety of studies have already begun.
The Facts about Dementia and Other Related Conditions Developed by the: University of Wisconsin Oshkosh and Wisconsin Department of Health Services.
Oxidative stress, cause of aging and disease! April 21/2016 ATCO.
Cognitive Impairment and Neural Pregenitor Cell Destruction (on Lister hooded rats) as a Result of Chemotherapy Morgan Earle, Department of Biological.
Protein conformational disorders
Sleep Deprivation, Exercise, and Anxiety
Fus1 KO female mice have olfactory and spatial memory impairments and
Ying Cheng (1st-year PhD), supervised by Dr Gayle Doherty
Alzheimer’s Disease.
COGNITIVE DECLINE IN THE WORKPLACE
Methods Objectives Results Conclusions References
Volume 24, Issue 2, Pages (August 2016)
Volume 71, Issue 4, Pages (August 2011)
Drugs for Degenerative Diseases of the Nervous System
Volume 81, Issue 6, Pages (March 2014)
Volume 11, Issue 2, Pages (April 2015)
Volume 16, Issue 6, Pages (August 2016)
Glucose Metabolism: A Sweet Relief of Alzheimer’s Disease
Volume 151, Issue 2, Pages (October 2012)
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Volume 21, Issue 4, Pages (April 2015)
Volume 93, Issue 3, Pages e5 (February 2017)
CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease  Fang Huang, Minghui Wang, Rong Liu, Jian-Zhi Wang, Eric Schadt, Vahram.
Male FBN-ARO-KO mice exhibit cognitive defects but normal locomotor activity and anxiety levels. Male FBN-ARO-KO mice exhibit cognitive defects but normal.
Presentation transcript:

Behavioral Effects of SQSTM1/p62 Overexpression in Mice: Support for a Mitochondrial Role in Depression and Anxiety Michael Lamar Seibenhener, Ph.D. Department of Biological Sciences, Auburn University

Quick Facts about Alzheimer’s Disease and Dementia: Leading cause of death in the United States Currently more than 5 million people in the United States are living with Alzheimer’s Disease 1 in 3 elderly people will die with Alzheimer’s or another form of dementia 2014 Costs of Dementia $603 BILLION 2050 Costs of Dementia $3.9 TRILLION (current dollars) 2050 Worldwide Cases of Dementia 150 MILLION 2015 Worldwide Cases of Dementia 47.5 MILLION

A biomarker, or biological marker, generally refers to a measured characteristic which may be used as an indicator of some biological state or condition. Imaging/PET Scans Biological/Biochemical Histochemical Amyloid plaques

Oxidative Stress Mutations UPS Dysfunction Ageing Prion Transmission TRIGGERSPRIMARY RESPONSEPATHOLOGY Ciechanover and Brundin, 2003 Neuron 40:427 SQSTM1/p62 is a component of ALL aggregates/inclusions Pathogenesis of Neurodegeneration

Adapted from: Salminen, et.al Progress in Neurobiology 96:87-95 SQSTM1/p62 Neurodegenerative Pathologies component of specific pathological protein aggregates Ubiquitin – Proteasome Degradation removal of misfolded or damaged proteins Mitophagy/Autophagy removal of defective mitochondria and proteins

p62 shows the potential to be used as a biomarker for Neurodegenerative Disease. Kah-Leong Lim Kah-Leong Lim and Cheng-Wu Zhang Front. Neurol., 08 April 2013Cheng-Wu Zhang SQSTM1/ p62

Examine the relationship between SQSTM1/p62 and mitochondrial functionality under physiological conditions

p62 Regulation of Mitochondrial Morphology WT MEF Cells KO MEF Cells + myc-p62 Mitochondria stained with MitoTracker Red p62 plays a role in regulating mitochondrial morphology

p62 and Mitochondrial Functionality p62 not only regulates morphology but also affects mitochondrial metabolism and energy production

p62 and the Mitochondrial Genome p62 protects mitochondrial genome integrity by a TFAM import related process. Dr. Yifeng Du, Wooten Lab

p62 plays an active role in affecting mitochondrial morphology and functionality. Reintroduction of p62 to a null-background restores mitochondrial function. Overexpression of p62 improves mitochondrial functionality above what is seen in WT.

Overexpress SQSTM1/p62 in a mouse model. examine its effects on mitochondrial dynamics mitochondrial relationship to mouse behavior anxiolytic behaviors and learning and memory

WT p62KO Mitochondrial Function and Behavior Patterns in p62KO Mice p62KO mice exhibit significant levels of mitochondrial dysfunction. Loss of p62 results in behavior patterns similar to those seen in Alzheimer’s Disease. WTKO ROS Hippocampal Neurons Change in mitochondrial morphology in p62KO Decrease ATP production in p62KO neurons Increase ROS in p62KO neurons Forced Swim Test - Depression Increased depression like behavior in p62KO mice Elevated Plus Maze - Anxiety Increased anxiety in p62KO mice

Expression of EGFP-p62 in Mouse Tissue EGFP-p62 was effectively expressed in mouse brain.

Mitochondrial Metabolism in OEp62 in Hippocampus p62 overexpression affects mitochondrial morphology and function.

Mitochondrial Functionality SQSTM1/p62 was effectively expressed in the brain, predominantly in the hippocampus, generating an overexpressing mouse model. Mitochondrial structure and metabolism improved in the presence of excess SQSTM1/p62. Does improved mitochondrial function correlate with positive changes in behaviors associated with neurodegenerative disease??

Excessive worry Sleep problems Panic attacks Compulsive behaviors Irrational fears Behaviors Associated with Alzheimer’s Disease

Open Field Maze Used to measure general locomotor activity and anxiety 50cm Distance traveled in the OFM was the same for overexpressing mice compared to WT. However, overexpressing mice spent more time in the inner area of the maze reflecting decreased anxiogenic behavior. measure activity for 10 minutes WT OEp62

Forced Swim Test Modification of the Porsalt Swim test used to measure despair and depression. measure activity for 6 minutes record behavior every 5 seconds 1.Immobile – floating with no or limited movement 2.Swimming – active movement around beaker 3.Climbing – actively trying to escape by climbing walls of beaker There is no measurable difference in immobility time between genotypes. However, recorded behaviors during the test did show significant improvement in depression like behaviors.

Affective Spectrum Disorder Behaviors Improvement in anxiety related behaviors. Distinguishing specific behaviors during the FST show overexpressing mice exhibit decreased depression/despair. Overall improvement in affective spectrum disorder behavior patterns in SQSTM1/p62 overexpressing mice.

Learning and Memory

Long Term Potentiation The long term enhancement of signal transmission between neurons. Overexpressing mice show improved LTP compared to WT.

Barnes Maze Noninvasive test for hippocampal dependent spatial learning and memory ADAPTATION (Day 1) – 4 trials/day; max – 3 min SPATIAL ACQUISITION (Day 2-5) – 4 trials/day; Max – 3 min PROBE TRIAL 1 (short term memory) (Day 5) – 2 hours post last acquisition trial; 90 second observation PROBE TRIAL 2 (long term memory) (Day 12) – 90 second observation Overexpressing mice showed slight improvement to latency in hidden box search times. No difference in short term memory was observed, however, long term memory was improved in overexpressing mice.

Learning and Memory Overexpression of SQSTM1/p62 shows enhanced LTP compared to WT. Spatial learning is slightly improved with overexpression of SQSTM1/p62. Spatial long term memory is strengthened with overexpression of SQSTM1/p62. Overall, learning and memory are improved with overexpression of SQSTM1/p62 in the brain.

Conclusions SQSTM1/p62 appears to be a prime candidate for a protein that changes mitochondrial functionality and also affects behavior making it a potential biomarker for neurodegenerative diseases. SQSTM1/p62 could be a novel target for potential drug discovery to treat anxiety and affective spectrum disorders as well as, improve cognitive function associated with neurodegenerative diseases. SQSTM1/p62 levels affect mitochondrial functionality as well as behavior patterns associated with neurodegenerative diseases.

Generation of p62OE mice C57BL/6-Tg(Thy1-SQSTM1)02MCWo/J (Stock# 27258)

Wish to Thank: Wooten Lab Members: Michael C. Wooten Yifeng Du Luis Calderilla Barbosa Jin Yan Denise Landers Others: Jorge Moscat Maria-Theresa Diaz-Meco Mike Irwin Carl Pinkert Vishnu Suppiramaniam Kodeeswaran Parameshwaran

Qitao Ran, UT Health Science Center